5 DNA Stocks Billionaires Are Loading Up On

4. Invitae Corporation (NYSE:NVTA)

Number of Hedge Fund Holders: 22

Number of Billionaire Investors: 9

Invitae Corporation (NYSE:NVTA) is a genetics company that offers genetic information to enhance healthcare in the United States, Canada, and internationally. The company offers genetic testing for hereditary cancer, precision oncology, women’s health, and rare diseases. Invitae Corporation (NYSE:NVTA) also specializes in pharmacogenomics, digital health solutions, and health data services. It is one of the most popular DNA stocks among billionaires as of Q1 2023. 

On May 9, Invitae Corporation (NYSE:NVTA) reported a Q1 non-GAAP EPS of -$0.37 and a revenue of $117.36 million, outperforming Wall Street estimates by $0.03 and $0.79 million, respectively. 

According to Insider Monkey’s first quarter database, 22 hedge funds were long Invitae Corporation (NYSE:NVTA), with collective stakes worth $81.1 million. Billionaire David Shaw’s D E Shaw is a prominent position holder in the company. 

Follow Invitae Corp (NYSE:NVTA)